Sulfasalazine therapy for juvenile rheumatoid arthritis

Journal of the Formosan Medical Association

Volumn 101, Issue 2, 2002, Pages 110-116

  Chen, Chia Chun ^a   Lin, Yu Tsan ^a   Yang, Yao Hsu ^a   Chiang, Bor Luen ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Adverse effect; Efficacy; Juvenile rheumatoid arthritis; Sulfasalazine

Indexed keywords

ANTIRHEUMATIC AGENT; AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTOTOXIC AGENT; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; SALAZOSULFAPYRIDINE; STEROID;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; EPIGASTRIC PAIN; FEMALE; FOLLOW UP; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; MALE; MEDICAL RECORD; NAUSEA AND VOMITING; RASH; RELAPSE; REMISSION; RETROSPECTIVE STUDY; TIME; TREATMENT OUTCOME;

ADOLESCENT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, JUVENILE RHEUMATOID; AZATHIOPRINE; CHILD; CHILD, PRESCHOOL; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; RETROSPECTIVE STUDIES; SULFASALAZINE; TREATMENT OUTCOME;

EID: 0036309018     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Auranofin in the treatment of juvenile rheumatoid arthritis: Results of the USA-USSR double-blind, placebo-controlled trial
2. Penicillamine and hydroxychloroquine in the treatment of severe juvenile rheumatoid arthritis
3. Methotrexate in resistant juvenile rheumatoid arthritis
4. The primary cause of rheumatoid arthritis is an infection - The infectious agent exists in milk
5. The treatment of rheumatic polyarthritis with acid azo compounds
6. Salazopyrin in the treatment of rheumatoid arthritis
7. Salazopyrin in rheumatoid arthritis
8. Sulphasalazine in rheumatoid arthritis
9. Sulphasalazine in rheumatoid arthritis: Long term tolerability in 432 patients monitored for 2 to 15 years
10. Sulphasalazine in rheumatoid arthritis: A double-blind comparison of sulphasalazine with placebo and sodium aurothiomalate
11. Sulfasalazine in rheumatoid arthritis: A double-blind, placebo-controlled trial
12. A controlled trial comparing sulfasalazine, gold sodium thiomalate, and placebo in rheumatoid arthritis
13. Sulfasalazine in early rheumatoid arthritis: A 48-week double-blind, prospective, placebo-controlled study
14. Sulfasalazine in the treatment of juvenile rheumatoid arthritis: A preliminary open trial
15. Sulphasalazine in juvenile rheumatoid arthritis
16. A multicenter pilot study of sulphasalazine in juvenile chronic arthritis
17. Sulfasalazine treatment in juvenile chronic arthritis: An open study
18. Sulphasalazine in the treatment of pauciarticular-onset juvenile chronic arthritis
19. Sulfasalazine therapy for juvenile rheumatoid arthritis
20. Sulphasalazine: An alternative drug for second-line treatment of juvenile chronic arthritis
21. Sulfasalazine in the treatment of juvenile chronic arthritis: A randomized, double-blind, placebo-controlled, multicenter study
22. Current proposed revision of JRA criteria
23. Absorption, metabolism and excretion of salazosulfapyridine in man
24. Sulfasalazine in the rheumatic disease
25. Which component of sulphasalazine is active in rheumatoid arthritis?
26. A study to determine the active moiety of sulphasalazine in rheumatoid arthritis
27. Is there a disease-modifying drug for juvenile chronic arthritis?
28. Side effects profile of 200 patients with inflammatory arthritis treated with sulfasalazine
29. Sulphasalazine induced hepatitis in juvenile rheumatoid arthritis
30. Toxicity of sulfasalazine in systemic juvenile chronic arthritis
31. The use of sulphasalazine and azathioprine in combination to treat rheumatoid arthritis
32. Combination therapy with sulphasalazine and azathioprine
33. Long-term effects of azathioprine therapy for juvenile rheumatoid arthritis
34. Sulphasalazine inhibition of thiopurine methyltransferase: Possible mechanism for interaction with 6-mercaptopurine and azathioprine
35. Clinical implications of thiopurine methyltransferase: Optimization of drug dosage and potential drug interactions